IP Library Granted Patent US 8,641,959
Granted Patent B2
US 8,641,959 · App. 12/179,274 · Granted Feb 4, 2014

Antioxidant doping of crosslinked polymers to form non-eluting bearing components

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,641,959
App. No.
12/179,274
Granted
Feb 4, 2014
Kind
B2
Abstract

Methods provide a non-eluting antioxidant doped UHMWPE in the form of an implant bearing component. The process includes the steps of: (a) providing a preform; (b) irradiating the preform with γ-irradiation to crosslink the UHMWPE; (c) doping the crosslinked preform by exposing it to an antioxidant composition at a temperature below the melting point of the UHMWPE; (d) removing the doped material from contact with the antioxidant composition; and then (e) annealing by heating the doped material at a temperature above 30° C. and below the melting point of the UHMWPE; followed by (f) making an implant bearing component from the doped material, wherein at least 1 mm but no more than about 15 mm of material are removed to make the component.

Claims (35)

1. A method of incorporating a non-eluting amount of α-tocopherol into UHMWPE to make an implant component having a bearing surface, the method comprising:

(a) machining a consolidated UHMWPE or molding nascent UHMWPE powder to make a preform;

(b) irradiating the preform with high energy radiation to a dose of 5 to 20 MRad;

(c) doping the irradiated preform by exposing it to an antioxidant composition comprising α-tocopherol at a temperature greater than 30° C. and below the crystalline melting point of the UHMWPE;

(d) removing the doped preform from exposure to the antioxidant composition; and then

(e) homogenizing the doped preform by heating at a temperature above 30° C. and below the melting point of the UHMWPE; followed by

(f) making the implant component from the doped preform by machining greater than or equal to 1 mm of material but less than or equal to 15 mm from the doped preform to make the implant component, and

(g) packaging and sterilizing the implant component, wherein the vitamin E index throughout the implant is 0.01 or greater, and 0.2 or less.

2. A method according to claim 1 , wherein the high energy radiation is gamma radiation.

3. A method according to claim 1 , wherein the dose of gamma-irradiation is 6.5 MRad or greater.

4. A method according to claim 1 , wherein the doping is carried out at a temperature of 100° C to 130° C.

5. A method according to claim 1 , wherein the homogenizing step is carried out at a temperature of 100° C to 130° C.

6. A method according to claim 1 , wherein the antioxidant comprises greater than or equal to 50% by weight of α-tocopherol.

7. A method according to claim 1 , wherein the antioxidant composition is 100% by weight α-tocopherol.

8. A method according to claim 1 , wherein the implant component is characterized by a vitamin E index at the bearing surface of the component that is less than the saturation limit of vitamin E in the component at body temperature.

9. A method of making a non-eluting oxidation-resistant medical implant component comprising UHMWPE and vitamin E, wherein the vitamin E index throughout the implant is 0.01 or greater, and 0.2 or less, the method comprising:

(a) machining a consolidated UHMWPE article or molding a UHMWPE powder to make a preform;

(b) irradiating the preform with γ-irradiation at a dose of about 1 MRad to about 20 MRad;

(c) doping the irradiated preform by submerging it in vitamin E at a temperature of 100° C to 130° C for at least one hour;

(d) removing the preform from the vitamin E and heating for at least an additional hour at 100° C to 130° C; and then

(e) machining the preform to form the implant component; followed by

(f) sterilizing the implant component by exposing it to γ-irradiation at a dose of 1-4 MRad.

10. A method according to claim 9 , wherein the implant component is characterized by a vitamin E index at the surface of the component that is less than the saturation limit of vitamin E in the component at body temperature.

11. A method according to claim 9 , wherein the vitamin E index throughout and on the surface is less than or equal to 0.15.

12. A method according to claim 9 , wherein the vitamin E index throughout and on the surface is less than or equal to 0.10.

13. A method according to claim 9 , wherein the vitamin E comprises α-tocopherol.

14. A method according to claim 9 , comprising doping the irradiated preform in vitamin E for 1-24 hours and heating for an additional 1-400 hours after removing the preform from the vitamin E.

15. A process for making a non-eluting antioxidant doped UHMWPE bearing component, comprising:

(a) providing a UHMWPE preform;

(b) irradiating the preform at a dose of 5 to 20 MRad of gamma irradiation;

(c) doping the preform with an antioxidant comprising α-tocopherol;

(d) annealing the doped preform below its melting point;

(e) machining the preform to the shape of the bearing component, wherein from 1 to 15 mm of material is removed from the preform to make the component; and

(f) packaging and sterilizing the bearing component, wherein the vitamin E index throughout the implant is 0.01 or greater, and 0.2 or less.

16. A process according to claim 15 , comprising irradiating the preform to a dose of approximately 10 MRad.

Assignments (5)
RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241 Recorded Nov 23, 2015
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: LVB ACQUISITION, INC.; BIOMET, INC.; BIOMET 3I, LLC; BIOMET BIOLOGICS, LLC.; BIOMET EUROPE LTD.; BIOMET FAIR LAWN LLC; BIOMET HOLDINGS LTD.; BIOMET INTERNATIONAL LTD.; BIOMET LEASING, INC.; BIOMET MANUFACTURING CORPORATION; BIOMET MICROFIXATION, LLC; BIOMET ORTHOPEDICS, LLC; BIOMET SPORTS MEDICINE, LLC; BIOMET TRAVEL, INC.; BIOLECTRON, INC.; CROSS MEDICAL PRODUCTS, LLC; ELECTR-OBIOLOGY, LLC; EBI HOLDINGS, LLC; EBI, LLC; EBI MEDICAL SYSTEMS, LLC; BIOMET FLORIDA SERVICES, LLC; INTERPORE CROSS INTERNATIONAL, LLC; INTERPORE SPINE, LTD.; KIRSCHNER MEDICAL CORPORATION; IMPLANT INNOVATIONS HOLDINGS, LLC
Reel/Frame 037155/0082 →
CHANGE OF NAME Recorded Feb 3, 2014
From: BIOMET MANUFACTURING CORPORATION
To: BIOMET MANUFACTURING, LLC
Reel/Frame 032122/0053 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2014
From: BIOMET MANUFACTURING CORPORATION
To: BIOMET MANUFACTURING, LLC
Reel/Frame 032128/0493 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2010
From: SCHROEDER, DAVID W.; FREEDMAN, JORDAN H.
To: BIOMET MANUFACTURING CORP.
Reel/Frame 024936/0149 →
SECURITY AGREEMENT Recorded Nov 12, 2009
From: LVB ACQUISITION, INC.; BIOMET, INC.; BIOMET 3I, LLC; BIOMET BIOLOGICS, LLC; BIOMET EUROPE LTD.; BIOMET FAIR LAWN LLC; BIOMET HOLDINGS LTD.; BIOMET INTERNATIONAL LTD.; BIOMET LEASING, INC.; BIOMET MANUFACTURING CORPORATION; BIOMET MICROFIXATION, LLC; BIOMET ORTHOPEDICS, LLC; BIOMET SPORTS MEDICINE, LLC; BIOMET TRAVEL, INC.; BIOLECTRON, INC.; CROSS MEDICAL PRODUCTS, LLC; ELECTRO-BIOLOGY, LLC; EBI HOLDINGS, LLC; EBI, LLC; EBI MEDICAL SYSTEMS, LLC; BIOMET FLORIDA SERVICES, LLC; INTERPORE CROSS INTERNATIONAL, LLC; INTERPORE SPINE, LTD.; KIRSCHNER MEDICAL CORPORATION; IMPLANT INNOVATIONS HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT FOR THE SECURED PARTIES
Reel/Frame 023505/0241 →